Recursion Pharmaceuticals
RXRX
#4561
Rank
A$3.19 B
Marketcap
A$6.13
Share price
-0.49%
Change (1 day)
-43.85%
Change (1 year)

Market capitalization of Recursion Pharmaceuticals (RXRX)

Market cap: A$3.19 Billion

As of January 2026 Recursion Pharmaceuticals has a market cap of A$3.19 Billion. This makes Recursion Pharmaceuticals the world's 4561th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Recursion Pharmaceuticals from 2021 to 2025

End of year Market Cap

Year Marketcap Change
2025A$3.30 B-28.75%
2024A$4.64 B48.59%
2023A$3.12 B45.47%
2022A$2.14 B-46.21%
2021A$3.99 B
2026A$3.19 B-3.43%

End of Day market cap according to different sources

On Dec 31st, 2025 the market cap of Recursion Pharmaceuticals was reported to be:

A$3.18 Billion
by Nasdaq info icon info icon
A$3.19 Billion
by CompaniesMarketCap info icon info icon